Published in Health Risk Factor Week, June 5th, 2007
"Unfortunately, randomised trials of selective COX-2 inhibitors for cancer prevention have shown...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.